Predicting High-Risk Prostate Cancer Using Machine Learning Methods
Prostate cancer can be low- or high-risk to the patient’s health. Current screening on the basis of prostate-specific antigen (PSA) levels has a tendency towards both false positives and false negatives, both of which have negative consequences. We obtained a dataset of 35,875 patients fro...
Main Authors: | Henry Barlow, Shunqi Mao, Matloob Khushi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Data |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-5729/4/3/129 |
Similar Items
-
A new approach to prostate cancer screening
by: Filella Xavier, et al.
Published: (2023-08-01) -
Prognostic significance of Prostate-Specific Antigen (PSA) rate of change in patients with advanced prostate cancer
by: A E Aghaji, et al.
Published: (2005-01-01) -
Diagnostic value of free-to-total PSA proportion and PSA density in prostate cancer detection for prostate volumes >= 100 cc
by: Murat Zor, et al.
Published: (2018-12-01) -
Prostate-specific antigen nadir after high-dose-rate brachytherapy predicts long-term survival outcomes in high-risk prostate cancer
by: Hideyasu Tsumura, et al.
Published: (2016-04-01) -
Identification of Urine Biomarkers to Improve Eligibility for Prostate Biopsy and Detect High-Grade Prostate Cancer
by: Nagjie Alijaj, et al.
Published: (2022-02-01)